New Marketplace
Clip
Why Employers Drag Feet on Value-Based Insurance (04:04)

Lynn Garbee, Senior Director of Reimbursement and Collaborative Care at Cigna HealthCare, would like to see employers jump into the value-based insurance reimbursement world with two feet and collaborate with payers in creating a healthy workforce. So why are employers hesitating? What do employers value and want to invest in when it comes to value-based insurance and health care payment plans in general?

“We’re at a point now where there’s a give and take,” says David Lansky, President and CEO of the Pacific Business Group on Health. “I would like to think of it as a co-evolution that we have to undertake, where the constraints and the requirements of employers are shared with payers.” Employers want payers to back up their claims for which networks and services work by sharing credible, evidence-based innovation in both cost savings, quality improvement, and outcomes. In other words: transparency. Many employers are skeptical when plans say, “We’ve got this new program, this new network, this new centers of excellence program” without offering evidence to share with employees that these new arrangements are better, safer, higher-quality care.

What about limited and narrow networks? Harvard health care economist Leemore Dafny points to research on state health insurance marketplaces showing that narrow networks are associated with much lower premiums, and that consumers are electing to purchase these plans. “Yet employers are really dragging their feet,” she says.

Employers sponsored benefits before the Affordable Care Act because they wanted to get the right employees, and with the labor market tightening, they’re much less interested in creating benefit designs that cause friction, replies Bob Galvin, Equity Healthcare’s CEO. Additionally, employees don’t understand narrow networks in that they don’t understand why employers think one doctor is better than another.

“The other thing is that we’ve been a victim, in a sense, of our own success,” says Galvin, “which is that health care costs have been very flat over the past few years.” Costs have only gone up 1 or 2% for employers, which means that C-suite decision makers would rather focus their company’s money on other things. “If the labor market were wide open and health care costs were going up at 10%, you would get much more updated.”

“I’m disappointed to hear that executives are not concerned, because guess how they’re making those premiums not go up so much? They’re turfing it over to us [the employee/consumer],” says Dafny.

Galvin agrees, noting that it’s just part of the nature of where health care fits into the company. “It’s one of the flaws of employer-sponsored insurance. It is very difficult to get executives who are manufacturing airline parts or whatever to really understand this. They look at the costs. They want to make sure they can get labor. And if that’s okay, they want to run their companies.”

From the NEJM Catalyst event Navigating Payment Reform for Providers, Payers, and Pharma, held at Harvard Business School, November 2, 2017.

More From New Marketplace
Comparison of Certain Model Features in Blue Cross NC Blue Premier vs Next-Generation ACO Model vs BCBSMA Alternative Quality Contract

Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program

We believe North Carolina can be a model for the nation.

Small Molecule Drugs Facing Generic Competition - Orphan and Non-Orphan Drugs - Orphan Drug Act

It’s Time to Reform the Orphan Drug Act

Three proposals for improving the law to reflect 21st-century drug development practices.

Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Cautious Optimism That Value-Based Reimbursement Will Become Primary Revenue Model

Survey Snapshot: What Would Accelerate the Adoption of Value-Based Care?

NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.

Strongwater08_pullquote primary care value proposition and disruptive innovation

The Evolution of Primary Care: Embracing Innovation While Protecting the Core Value

Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.

Berns01_pullquote nephrologists dialysis facility joint venture conflicts of interest

Dialysis-Facility Joint-Venture Ownership — Hidden Conflicts of Interest

Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.

Fee-for-Service Continues to Account for the Majority of Revenue

New Marketplace Survey: Transitioning Payment Models: Fee-for-Service to Value-Based Care

In a survey of the NEJM Catalyst Insights Council sponsored by Optum, respondents express enthusiasm for value-based care but have conflicting opinions about just how far along that path they should go.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Engineering a Rapid Shift to Value-Based…

We believe North Carolina can be a model for the nation.

Engineering a Rapid Shift to Value-Based…

We believe North Carolina can be a model for the nation.

Bundled Payments

59 Articles

Building a “Hospital-within-Hospital” Model for Joint…

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now